SCHEMBL17401284

SCHEMBL17401284

CCCCCCCCCCCCCCC(=O)OCCN(C)CCN(C)C

nearest known ligand 0.84

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.84
DGKA P23743 1/20 0.65
PAM P19021 2/20 0.50
NAAA Q02083 1/20 0.50
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
TSHR P16473 1/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 2/20 0.46
ALDH1A1 P00352 1/20 0.46
KDM5A P29375 1/20 0.46
KDM4E B2RXH2 1/20 0.45
DUSP3 P51452 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR2C P28335 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17401281 1.00 DNM1 (0.84) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401285 1.00 DNM1 (0.84) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401282 1.00 DNM1 (0.84) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401283 1.00 DNM1 (0.84) DNM1DGKAPAMNAAAPRSS1
SCHEMBL14239731 0.93 DNM1 (0.83) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401275 0.93 DNM1 (0.83) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401279 0.93 DNM1 (0.83) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401277 0.93 DNM1 (0.83) DNM1DGKAPAMNAAAPRSS1
SCHEMBL17401274 0.93 DNM1 (0.83) DNM1DGKAPAMNAAAPRSS1
SCHEMBL26970342 0.93 DNM1 (0.83) DNM1DGKAPAMNAAAPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840479-B2 Polyamine-fatty acid derived lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-12-12 US disclosed
US-9840479-B2 Polyamine-fatty acid derived lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-12-12 US disclosed
WO-2016004202-A1 POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-07 WO disclosed
US-20160002178-A1 POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-07 US disclosed
US-20160002178-A1 POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002178-A1 POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF SGMS2, SGMS1, ARG2 DNM1 2046/4885DGKA 117/4885PAM 898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.